Decreased mitochondrial function in quiescent cells isolated from multicellular tumor spheroids.
Cells in the inner region of multicellular spheroids markedly reduce their oxygen consumption rate, presumably in response to their stressful microenvironment. To determine the mechanism behind this metabolic adaptation, we have investigated relative mitochondrial mass and mitochondrial function in cells isolated from different regions of tumor spheroids by using a combination of mitochondrial-specific fluorescent stains and flow cytometric analysis. Uptake of rhodamine 123 (R123) is driven by the mitochondrial membrane potential and thus reflects mitochondrial activity. Uptake of 10-nonyl-acridine orange (NAO) reflects total mitochondrial mass independently of activity because this compound binds to cardiolipin in the inner mitochondrial membrane. NAO fluorescence per unit cell volume only decreased 10-20% for cells from the inner spheroid region compared with those near the surface. There was greater than a twofold reduction in R123 fluorescence in the inner region cells, however. Thus, tumor cells in spheroids alter their rate of respiration predominately by downregulating mitochondrial function as opposed to degradation of mitochondria. There was a correlation between R123 staining per unit cell volume and the growth fraction of the cells from spheroids, but not for monolayer cultures. We also show a linear correlation between R123 staining and the rate of oxygen consumption for both monolayer- and spheroid-derived cells. After separating the inner region cells from the spheroid and replating them in monolayer culture, the R123 uptake recovered to normal levels prior to entry of the cells into S-phase. This reduction in mitochondrial function in quiescent cells from spheroids can explain the long period required for these cells to re-enter the cell cycle and may have important implications for the regulation of tumor cell oxygenation in vivo.
Freyer
J P
JP
Cell and Molecular Biology Group, Life Sciences Division, Los Alamos National Laboratory, New Mexico 87545, USA.
D000609:Aminoacridines / Q000493:pharmacokinetics; D000818:Animals; D001562:Benzimidazoles / Q000378:metabolism; D002453:Cell Cycle / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D019069:Cell Respiration / Q000502:physiology; D005434:Flow Cytometry; D005456:Fluorescent Dyes / Q000493:pharmacokinetics; D051379:Mice; D008928:Mitochondria / Q000378:metabolism*; D009374:Neoplasms, Experimental / Q000378:metabolism*; D010101:Oxygen Consumption / Q000502:physiology; D051381:Rats; D020112:Rhodamine 123; D012235:Rhodamines / Q000493:pharmacokinetics; D018874:Spheroids, Cellular / Q000502:physiology*; D014407:Tumor Cells, Cultured
D000609:Aminoacridines; D001562:Benzimidazoles; D005456:Fluorescent Dyes; D012235:Rhodamines; D020112:Rhodamine 123; C041691:10-N-nonylacridinium orange; C017807:bisbenzimide ethoxide trihydrochloride